Frequencies for first 10,000 rows of indi_pt variable in indi2011q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 1 0.01 0.01 ABDOMINAL DISCOMFORT | 5 0.05 0.06 ABDOMINAL DISTENSION | 2 0.02 0.08 ABDOMINAL INFECTION | 1 0.01 0.09 ABDOMINAL PAIN | 6 0.06 0.15 ABDOMINAL PAIN UPPER | 5 0.05 0.20 ABNORMAL BEHAVIOUR | 1 0.01 0.21 ABSCESS | 1 0.01 0.22 ACANTHAMOEBA KERATITIS | 4 0.04 0.26 ACCIDENTAL EXPOSURE | 3 0.03 0.29 ACIDOSIS | 1 0.01 0.30 ACNE | 57 0.57 0.87 ACNE CYSTIC | 1 0.01 0.88 ACNE PUSTULAR | 1 0.01 0.89 ACQUIRED HAEMOPHILIA | 2 0.02 0.91 ACROMEGALY | 4 0.04 0.95 ACUTE CORONARY SYNDROME | 3 0.03 0.98 ACUTE LEUKAEMIA | 2 0.02 1.00 ACUTE LYMPHOCYTIC LEUKAEMIA | 18 0.18 1.18 ACUTE MYELOID LEUKAEMIA | 16 0.16 1.34 ACUTE MYELOID LEUKAEMIA RECURRENT | 1 0.01 1.35 ACUTE MYOCARDIAL INFARCTION | 1 0.01 1.36 ADENOCARCINOMA | 1 0.01 1.37 ADENOMATOUS POLYPOSIS COLI | 1 0.01 1.38 ADENOMYOSIS | 1 0.01 1.39 ADHESION | 1 0.01 1.40 ADJUSTMENT DISORDER | 3 0.03 1.43 ADRENAL DISORDER | 1 0.01 1.44 ADULT T-CELL LYMPHOMA/LEUKAEMIA | 13 0.13 1.57 ADVERSE EVENT | 1 0.01 1.58 AFFECTIVE DISORDER | 15 0.15 1.73 AGITATION | 4 0.04 1.77 ALLERGY PROPHYLAXIS | 3 0.03 1.80 ALOPECIA | 4 0.04 1.84 AMPUTATION | 7 0.07 1.91 AMYLOIDOSIS | 1 0.01 1.92 AMYOTROPHIC LATERAL SCLEROSIS | 6 0.06 1.98 ANAEMIA | 12 0.12 2.10 ANAEMIA OF CHRONIC DISEASE | 1 0.01 2.11 ANAEMIA POSTOPERATIVE | 1 0.01 2.12 ANAESTHESIA | 10 0.10 2.22 ANAL CANCER | 2 0.02 2.24 ANAL CANCER RECURRENT | 2 0.02 2.26 ANALGESIC THERAPY | 14 0.14 2.40 ANDROGENETIC ALOPECIA | 1 0.01 2.41 ANEURYSM | 2 0.02 2.43 ANGER | 2 0.02 2.45 ANGINA PECTORIS | 15 0.15 2.60 ANGIOGRAM | 5 0.05 2.65 ANGIOSARCOMA | 1 0.01 2.66 ANKYLOSING SPONDYLITIS | 25 0.25 2.91 ANOGENITAL WARTS | 1 0.01 2.92 ANTI-INFECTIVE THERAPY | 1 0.01 2.93 ANTIALLERGIC THERAPY | 2 0.02 2.95 ANTIBIOTIC PROPHYLAXIS | 4 0.04 2.99 ANTIBIOTIC THERAPY | 5 0.05 3.04 ANTICOAGULANT THERAPY | 12 0.12 3.16 ANTIDEPRESSANT THERAPY | 2 0.02 3.18 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.19 ANTIFUNGAL PROPHYLAXIS | 7 0.07 3.26 ANTIPLATELET THERAPY | 2 0.02 3.28 ANTIRETROVIRAL THERAPY | 19 0.19 3.47 ANTITHROMBIN III DEFICIENCY | 1 0.01 3.48 ANTITUSSIVE THERAPY | 1 0.01 3.49 ANTIVIRAL PROPHYLAXIS | 4 0.04 3.53 ANTIVIRAL TREATMENT | 1 0.01 3.54 ANXIETY | 77 0.77 4.31 ANXIETY DISORDER | 1 0.01 4.32 AORTIC VALVE REPLACEMENT | 3 0.03 4.35 APATHY | 2 0.02 4.37 APHONIA | 2 0.02 4.39 APLASTIC ANAEMIA | 15 0.15 4.54 APPENDIX DISORDER | 1 0.01 4.55 APPETITE DISORDER | 1 0.01 4.56 ARRHYTHMIA | 4 0.04 4.60 ARTERIOGRAM CORONARY | 1 0.01 4.61 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 4.62 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 4.63 ARTHRALGIA | 28 0.28 4.91 ARTHRITIS | 20 0.20 5.11 ARTHROPATHY | 5 0.05 5.16 ARTHROPOD INFESTATION | 1 0.01 5.17 ARTIFICIAL MENOPAUSE | 1 0.01 5.18 ASPERGER'S DISORDER | 1 0.01 5.19 ASPERGILLOSIS | 6 0.06 5.25 ASPIRATION BONE MARROW | 1 0.01 5.26 ASPLENIA | 1 0.01 5.27 ASSISTED FERTILISATION | 1 0.01 5.28 ASTHENIA | 2 0.02 5.30 ASTHENOPIA | 1 0.01 5.31 ASTHMA | 65 0.65 5.96 ASTROCYTOMA | 1 0.01 5.97 ASYMPTOMATIC HIV INFECTION | 2 0.02 5.99 ATRIAL FIBRILLATION | 157 1.57 7.56 ATRIAL FLUTTER | 1 0.01 7.57 ATRIAL SEPTAL DEFECT | 1 0.01 7.58 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 20 0.20 7.78 ATYPICAL MYCOBACTERIAL INFECTION | 3 0.03 7.81 AXONAL NEUROPATHY | 1 0.01 7.82 B PRECURSOR TYPE ACUTE LEUKAEMIA | 8 0.08 7.90 B-CELL LYMPHOMA | 3 0.03 7.93 B-CELL SMALL LYMPHOCYTIC LYMPHOMA | 1 0.01 7.94 BACK DISORDER | 6 0.06 8.00 BACK PAIN | 57 0.57 8.57 BACTERIAL INFECTION | 4 0.04 8.61 BALANCE DISORDER | 3 0.03 8.64 BAND SENSATION | 2 0.02 8.66 BARRETT'S OESOPHAGUS | 1 0.01 8.67 BASEDOW'S DISEASE | 1 0.01 8.68 BEHCET'S SYNDROME | 4 0.04 8.72 BENIGN PROSTATIC HYPERPLASIA | 10 0.10 8.82 BILE DUCT CANCER | 1 0.01 8.83 BILE DUCT STONE | 1 0.01 8.84 BILIARY TRACT DISORDER | 1 0.01 8.85 BIPOLAR DISORDER | 52 0.52 9.37 BIPOLAR I DISORDER | 7 0.07 9.44 BLADDER CANCER | 6 0.06 9.50 BLADDER CANCER STAGE 0, WITH CANCER I.. | 1 0.01 9.51 BLADDER DISORDER | 2 0.02 9.53 BLOOD ANTIDIURETIC HORMONE DECREASED | 1 0.01 9.54 BLOOD CALCIUM | 1 0.01 9.55 BLOOD CHOLESTEROL | 13 0.13 9.68 BLOOD CHOLESTEROL ABNORMAL | 9 0.09 9.77 BLOOD CHOLESTEROL INCREASED | 63 0.63 10.40 BLOOD CORTICOTROPHIN DECREASED | 1 0.01 10.41 BLOOD COUNT ABNORMAL | 1 0.01 10.42 BLOOD DISORDER | 1 0.01 10.43 BLOOD FOLLICLE STIMULATING HORMONE DE.. | 1 0.01 10.44 BLOOD GLUCOSE ABNORMAL | 1 0.01 10.45 BLOOD GLUCOSE INCREASED | 2 0.02 10.47 BLOOD IRON | 1 0.01 10.48 BLOOD LUTEINISING HORMONE DECREASED | 1 0.01 10.49 BLOOD PHOSPHORUS ABNORMAL | 1 0.01 10.50 BLOOD POTASSIUM ABNORMAL | 1 0.01 10.51 BLOOD PRESSURE | 28 0.28 10.79 BLOOD PRESSURE ABNORMAL | 11 0.11 10.90 BLOOD PRESSURE INCREASED | 6 0.06 10.96 BLOOD PRESSURE MANAGEMENT | 3 0.03 10.99 BLOOD TESTOSTERONE DECREASED | 1 0.01 11.00 BLOOD TESTOSTERONE INCREASED | 1 0.01 11.01 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 11.02 BLOOD TRIGLYCERIDES | 1 0.01 11.03 BLOOD TRIGLYCERIDES INCREASED | 1 0.01 11.04 BLOOD URIC ACID | 1 0.01 11.05 BODY TEMPERATURE INCREASED | 2 0.02 11.07 BONE DISORDER | 5 0.05 11.12 BONE MARROW CONDITIONING REGIMEN | 14 0.14 11.26 BONE MARROW FAILURE | 4 0.04 11.30 BONE MARROW TRANSPLANT | 4 0.04 11.34 BONE NEOPLASM MALIGNANT | 1 0.01 11.35 BONE PAIN | 3 0.03 11.38 BONE SARCOMA | 10 0.10 11.48 BORDERLINE PERSONALITY DISORDER | 1 0.01 11.49 BRAIN INJURY | 3 0.03 11.52 BRAIN NEOPLASM MALIGNANT | 1 0.01 11.53 BREAKTHROUGH PAIN | 4 0.04 11.57 BREAST CANCER | 77 0.77 12.34 BREAST CANCER FEMALE | 4 0.04 12.38 BREAST CANCER METASTATIC | 23 0.23 12.61 BREAST CANCER STAGE IV | 3 0.03 12.64 BRONCHIAL DISORDER | 1 0.01 12.65 BRONCHIAL HYPERREACTIVITY | 3 0.03 12.68 BRONCHIECTASIS | 1 0.01 12.69 BRONCHIOLITIS | 3 0.03 12.72 BRONCHITIS | 24 0.24 12.96 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 12.97 BRONCHOPULMONARY DYSPLASIA | 1 0.01 12.98 BURKITT'S LYMPHOMA | 3 0.03 13.01 BURSITIS | 2 0.02 13.03 CANCER PAIN | 5 0.05 13.08 CARCINOID SYNDROME | 2 0.02 13.10 CARCINOID TUMOUR | 1 0.01 13.11 CARDIAC ABLATION | 1 0.01 13.12 CARDIAC DISORDER | 30 0.30 13.42 CARDIAC FAILURE | 11 0.11 13.53 CARDIAC FAILURE CHRONIC | 7 0.07 13.60 CARDIAC FAILURE CONGESTIVE | 5 0.05 13.65 CARDIAC OPERATION | 2 0.02 13.67 CARDIAC VALVE DISEASE | 1 0.01 13.68 CARDIAC VALVE PROSTHESIS USER | 1 0.01 13.69 CARDIOMYOPATHY | 1 0.01 13.70 CARDIOVASCULAR DISORDER | 1 0.01 13.71 CARDIOVASCULAR EVENT PROPHYLAXIS | 2 0.02 13.73 CARDIOVERSION | 1 0.01 13.74 CATAPLEXY | 3 0.03 13.77 CATARACT OPERATION | 1 0.01 13.78 CD4 LYMPHOCYTES DECREASED | 3 0.03 13.81 CELLULITIS | 3 0.03 13.84 CENTRAL NERVOUS SYSTEM LESION | 2 0.02 13.86 CEREBROVASCULAR ACCIDENT | 4 0.04 13.90 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 8 0.08 13.98 CERUMEN IMPACTION | 1 0.01 13.99 CHEMOTHERAPY | 14 0.14 14.13 CHEST PAIN | 3 0.03 14.16 CHOLELITHIASIS | 1 0.01 14.17 CHRONIC HEPATITIS | 1 0.01 14.18 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 2 0.02 14.20 CHRONIC LYMPHOCYTIC LEUKAEMIA | 11 0.11 14.31 CHRONIC MYELOID LEUKAEMIA | 40 0.40 14.71 CHRONIC MYELOID LEUKAEMIA (IN REMISSI.. | 1 0.01 14.72 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 63 0.63 15.35 CHRONIC SINUSITIS | 3 0.03 15.38 CLOSTRIDIAL INFECTION | 4 0.04 15.42 CLOSTRIDIUM DIFFICILE COLITIS | 2 0.02 15.44 CNS GERMINOMA | 1 0.01 15.45 COLITIS | 1 0.01 15.46 COLITIS ULCERATIVE | 38 0.38 15.84 COLON CANCER | 11 0.11 15.95 COLON CANCER METASTATIC | 3 0.03 15.98 COLONIC STENOSIS | 1 0.01 15.99 COLONOSCOPY | 1 0.01 16.00 COLORECTAL CANCER | 31 0.31 16.31 COLORECTAL CANCER METASTATIC | 9 0.09 16.40 COLORECTAL CANCER STAGE III | 2 0.02 16.42 COMPLETED SUICIDE | 5 0.05 16.47 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 16.48 COMPUTERISED TOMOGRAM | 12 0.12 16.60 COMPUTERISED TOMOGRAM ABDOMEN | 2 0.02 16.62 COMPUTERISED TOMOGRAM HEAD | 1 0.01 16.63 CONJUNCTIVITIS ALLERGIC | 1 0.01 16.64 CONSTIPATION | 44 0.44 17.08 CONTRACEPTION | 168 1.68 18.76 CONTRAST MEDIA ALLERGY | 2 0.02 18.78 CONVULSION | 47 0.47 19.25 CONVULSION PROPHYLAXIS | 2 0.02 19.27 CORONARY ARTERIAL STENT INSERTION | 2 0.02 19.29 CORONARY ARTERY BYPASS | 5 0.05 19.34 CORONARY ARTERY DISEASE | 19 0.19 19.53 COUGH | 7 0.07 19.60 CREST SYNDROME | 2 0.02 19.62 CROHN'S DISEASE | 130 1.30 20.92 CRYOGLOBULINAEMIA | 5 0.05 20.97 CRYPTOCOCCOSIS | 1 0.01 20.98 CUSHING'S SYNDROME | 1 0.01 20.99 CYST | 2 0.02 21.01 CYSTIC FIBROSIS | 5 0.05 21.06 CYSTITIS NONINFECTIVE | 1 0.01 21.07 CYSTOSCOPY | 1 0.01 21.08 CYTOMEGALOVIRUS INFECTION | 3 0.03 21.11 DEATH OF RELATIVE | 1 0.01 21.12 DECREASED APPETITE | 3 0.03 21.15 DEEP VEIN THROMBOSIS | 10 0.10 21.25 DEMENTIA | 11 0.11 21.36 DEMENTIA ALZHEIMER'S TYPE | 14 0.14 21.50 DENTAL CARE | 2 0.02 21.52 DENTAL DISORDER PROPHYLAXIS | 1 0.01 21.53 DENTAL FLUORIDE THERAPY | 1 0.01 21.54 DENTAL OPERATION | 2 0.02 21.56 DEPRESSED MOOD | 2 0.02 21.58 DEPRESSION | 177 1.77 23.35 DEPRESSIVE SYMPTOM | 2 0.02 23.37 DERMATITIS | 1 0.01 23.38 DERMATITIS ATOPIC | 6 0.06 23.44 DEVICE THERAPY | 2 0.02 23.46 DIABETES MELLITUS | 208 2.08 25.54 DIABETES MELLITUS INADEQUATE CONTROL | 1 0.01 25.55 DIABETES PROPHYLAXIS | 1 0.01 25.56 DIABETIC KETOACIDOSIS | 1 0.01 25.57 DIABETIC NEPHROPATHY | 1 0.01 25.58 DIABETIC NEUROPATHY | 3 0.03 25.61 DIABETIC RETINOPATHY | 1 0.01 25.62 DIAGNOSTIC PROCEDURE | 1 0.01 25.63 DIALYSIS | 2 0.02 25.65 DIARRHOEA | 14 0.14 25.79 DIFFUSE LARGE B-CELL LYMPHOMA | 7 0.07 25.86 DISBACTERIOSIS | 1 0.01 25.87 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 25.88 DIURETIC THERAPY | 2 0.02 25.90 DIVERTICULITIS | 1 0.01 25.91 DIZZINESS | 5 0.05 25.96 DRUG DEPENDENCE | 10 0.10 26.06 DRUG INTOLERANCE | 1 0.01 26.07 DRUG THERAPY | 2 0.02 26.09 DRUG TOXICITY PROPHYLAXIS | 3 0.03 26.12 DRY EYE | 7 0.07 26.19 DRY SKIN | 2 0.02 26.21 DYSGEUSIA | 2 0.02 26.23 DYSLIPIDAEMIA | 11 0.11 26.34 DYSMENORRHOEA | 12 0.12 26.46 DYSPEPSIA | 16 0.16 26.62 DYSPNOEA | 5 0.05 26.67 EAR INFECTION | 1 0.01 26.68 EISENMENGER'S SYNDROME | 1 0.01 26.69 ELECTROLYTE SUBSTITUTION THERAPY | 9 0.09 26.78 EMBOLISM | 2 0.02 26.80 EMBOLISM VENOUS | 1 0.01 26.81 EMOTIONAL DISORDER | 1 0.01 26.82 EMPHYSEMA | 11 0.11 26.93 ENCEPHALITIS | 2 0.02 26.95 ENCEPHALOPATHY | 1 0.01 26.96 ENDOMETRIAL CANCER STAGE III | 2 0.02 26.98 ENDOMETRIOSIS | 3 0.03 27.01 ENDOSCOPY UPPER GASTROINTESTINAL TRACT | 1 0.01 27.02 ENDOTRACHEAL INTUBATION | 1 0.01 27.03 ENERGY INCREASED | 1 0.01 27.04 ENTERITIS | 1 0.01 27.05 EPIDIDYMITIS | 5 0.05 27.10 EPILEPSY | 40 0.40 27.50 ERECTILE DYSFUNCTION | 42 0.42 27.92 ERYTHEMA | 1 0.01 27.93 ESSENTIAL HYPERTENSION | 2 0.02 27.95 ESSENTIAL THROMBOCYTHAEMIA | 3 0.03 27.98 EUSTACHIAN TUBE DISORDER | 1 0.01 27.99 EVANS SYNDROME | 5 0.05 28.04 EWING'S SARCOMA | 5 0.05 28.09 EWING'S SARCOMA RECURRENT | 7 0.07 28.16 EXTRAPYRAMIDAL DISORDER | 2 0.02 28.18 EYE DISORDER | 2 0.02 28.20 FABRY'S DISEASE | 3 0.03 28.23 FACTOR VIII DEFICIENCY | 2 0.02 28.25 FAECES HARD | 2 0.02 28.27 FATIGUE | 2 0.02 28.29 FEELING OF RELAXATION | 1 0.01 28.30 FIBROMYALGIA | 19 0.19 28.49 FIBROSIS | 1 0.01 28.50 FLATULENCE | 1 0.01 28.51 FLUID IMBALANCE | 1 0.01 28.52 FLUID REPLACEMENT | 1 0.01 28.53 FLUID RETENTION | 6 0.06 28.59 FOOT FRACTURE | 2 0.02 28.61 FUNGAL INFECTION | 1 0.01 28.62 FUNGAL SKIN INFECTION | 1 0.01 28.63 FURUNCLE | 1 0.01 28.64 GAIT DISTURBANCE | 5 0.05 28.69 GASTRIC CANCER | 2 0.02 28.71 GASTRIC DISORDER | 8 0.08 28.79 GASTRIC PH DECREASED | 1 0.01 28.80 GASTRIC ULCER | 4 0.04 28.84 GASTRITIS | 22 0.22 29.06 GASTRITIS PROPHYLAXIS | 6 0.06 29.12 GASTRODUODENAL ULCER | 1 0.01 29.13 GASTROINTESTINAL DISORDER | 7 0.07 29.20 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 29.21 GASTROINTESTINAL HYPERMOTILITY | 1 0.01 29.22 GASTROINTESTINAL INFECTION | 1 0.01 29.23 GASTROINTESTINAL INFLAMMATION | 1 0.01 29.24 GASTROINTESTINAL NEOPLASM | 1 0.01 29.25 GASTROINTESTINAL STROMAL TUMOUR | 13 0.13 29.38 GASTROOESOPHAGEAL CANCER | 10 0.10 29.48 GASTROOESOPHAGEAL REFLUX DISEASE | 54 0.54 30.02 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 1 0.01 30.03 GAUCHER'S DISEASE | 5 0.05 30.08 GENERAL ANAESTHESIA | 1 0.01 30.09 GENERALISED ANXIETY DISORDER | 3 0.03 30.12 GENITAL INFECTION FEMALE | 1 0.01 30.13 GLAUCOMA | 25 0.25 30.38 GLIOBLASTOMA | 1 0.01 30.39 GLOMERULONEPHRITIS CHRONIC | 4 0.04 30.43 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE | 1 0.01 30.44 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 30.46 GLYCOGEN STORAGE DISEASE TYPE II | 2 0.02 30.48 GOITRE | 1 0.01 30.49 GOUT | 14 0.14 30.63 GRAFT COMPLICATION | 3 0.03 30.66 GRAFT VERSUS HOST DISEASE | 7 0.07 30.73 GROWTH HORMONE DEFICIENCY | 6 0.06 30.79 GROWTH RETARDATION | 1 0.01 30.80 HAEMATOCRIT DECREASED | 1 0.01 30.81 HAEMATOPOIETIC STEM CELL MOBILISATION | 2 0.02 30.83 HAEMATURIA | 1 0.01 30.84 HAEMOCHROMATOSIS | 1 0.01 30.85 HAEMOGLOBIN DECREASED | 1 0.01 30.86 HAEMOLYSIS | 1 0.01 30.87 HAEMOLYTIC URAEMIC SYNDROME | 1 0.01 30.88 HAEMORRHAGE PROPHYLAXIS | 1 0.01 30.89 HAEMORRHOIDS | 4 0.04 30.93 HAIRY CELL LEUKAEMIA | 2 0.02 30.95 HALLUCINATION | 1 0.01 30.96 HEAD AND NECK CANCER | 5 0.05 31.01 HEADACHE | 35 0.35 31.36 HEART RATE INCREASED | 2 0.02 31.38 HEART RATE IRREGULAR | 3 0.03 31.41 HEART TRANSPLANT | 9 0.09 31.50 HEART VALVE REPLACEMENT | 1 0.01 31.51 HEAT RASH | 1 0.01 31.52 HELICOBACTER GASTRITIS | 3 0.03 31.55 HELMINTHIC INFECTION | 1 0.01 31.56 HEMIPARESIS | 2 0.02 31.58 HEPATIC CIRRHOSIS | 3 0.03 31.61 HEPATIC ENZYME INCREASED | 1 0.01 31.62 HEPATIC NEOPLASM MALIGNANT | 16 0.16 31.78 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 31.79 HEPATITIS | 1 0.01 31.80 HEPATITIS B | 11 0.11 31.91 HEPATITIS C | 42 0.42 32.33 HEPATOSPLENIC CANDIDIASIS | 1 0.01 32.34 HEREDITARY ANGIOEDEMA | 2 0.02 32.36 HEREDITARY HAEMOCHROMATOSIS | 1 0.01 32.37 HERNIA | 1 0.01 32.38 HERPES SIMPLEX | 1 0.01 32.39 HERPES VIRUS INFECTION | 2 0.02 32.41 HERPES ZOSTER | 7 0.07 32.48 HIATUS HERNIA | 2 0.02 32.50 HICCUPS | 1 0.01 32.51 HIGH DENSITY LIPOPROTEIN ABNORMAL | 1 0.01 32.52 HIP ARTHROPLASTY | 3 0.03 32.55 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 32.56 HIV INFECTION | 73 0.73 33.29 HODGKIN'S DISEASE | 9 0.09 33.38 HORMONE REPLACEMENT THERAPY | 15 0.15 33.53 HORMONE THERAPY | 3 0.03 33.56 HOT FLUSH | 3 0.03 33.59 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 2 0.02 33.61 HYDROTHERAPY | 1 0.01 33.62 HYPERBILIRUBINAEMIA | 1 0.01 33.63 HYPERCALCAEMIA | 2 0.02 33.65 HYPERCHLORHYDRIA | 3 0.03 33.68 HYPERCHOLESTEROLAEMIA | 37 0.37 34.05 HYPERGLYCAEMIA | 2 0.02 34.07 HYPERHIDROSIS | 1 0.01 34.08 HYPERKALAEMIA | 2 0.02 34.10 HYPERKERATOSIS | 1 0.01 34.11 HYPERLIPIDAEMIA | 22 0.22 34.33 HYPERPARATHYROIDISM | 2 0.02 34.35 HYPERPARATHYROIDISM PRIMARY | 1 0.01 34.36 HYPERPARATHYROIDISM SECONDARY | 6 0.06 34.42 HYPERPHOSPHATAEMIA | 9 0.09 34.51 HYPERSENSITIVITY | 22 0.22 34.73 HYPERTENSION | 421 4.21 38.94 HYPERTHYROIDISM | 3 0.03 38.97 HYPERTONIA | 1 0.01 38.98 HYPERTONIC BLADDER | 3 0.03 39.01 HYPERURICAEMIA | 14 0.14 39.15 HYPOAESTHESIA | 3 0.03 39.18 HYPOALBUMINAEMIA | 2 0.02 39.20 HYPOCALCAEMIA | 2 0.02 39.22 HYPOCHOLESTEROLAEMIA | 2 0.02 39.24 HYPOGAMMAGLOBULINAEMIA | 3 0.03 39.27 HYPOKALAEMIA | 2 0.02 39.29 HYPOMAGNESAEMIA | 1 0.01 39.30 HYPONATRAEMIA | 1 0.01 39.31 HYPOPITUITARISM | 3 0.03 39.34 HYPOTHYROIDISM | 50 0.50 39.84 HYPOTONIA | 1 0.01 39.85 HYPOVITAMINOSIS | 2 0.02 39.87 HYPOXIA | 1 0.01 39.88 HYSTERECTOMY | 5 0.05 39.93 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 85 0.85 40.78 ILEITIS | 1 0.01 40.79 ILEUS PARALYTIC | 1 0.01 40.80 ILL-DEFINED DISORDER | 17 0.17 40.97 IMMUNISATION | 1 0.01 40.98 IMMUNODEFICIENCY | 1 0.01 40.99 IMMUNODEFICIENCY COMMON VARIABLE | 5 0.05 41.04 IMMUNOGLOBULIN THERAPY | 3 0.03 41.07 IMMUNOSUPPRESSION | 38 0.38 41.45 INADEQUATE LUBRICATION | 1 0.01 41.46 INCONTINENCE | 2 0.02 41.48 INDUCTION OF ANAESTHESIA | 6 0.06 41.54 INDWELLING CATHETER MANAGEMENT | 1 0.01 41.55 INFECTED SKIN ULCER | 2 0.02 41.57 INFECTION | 25 0.25 41.82 INFECTION PARASITIC | 3 0.03 41.85 INFECTION PROPHYLAXIS | 24 0.24 42.09 INFECTIOUS PERITONITIS | 1 0.01 42.10 INFERTILITY | 1 0.01 42.11 INFILTRATION ANAESTHESIA | 4 0.04 42.15 INFLAMMATION | 8 0.08 42.23 INFLAMMATORY BOWEL DISEASE | 24 0.24 42.47 INFLUENZA | 1 0.01 42.48 INFUSION | 5 0.05 42.53 INJURY | 1 0.01 42.54 INSOMNIA | 58 0.58 43.12 INTENTIONAL DRUG MISUSE | 1 0.01 43.13 INTENTIONAL SELF-INJURY | 3 0.03 43.16 INTERSTITIAL LUNG DISEASE | 3 0.03 43.19 INTERTRIGO | 1 0.01 43.20 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 43.22 INTERVERTEBRAL DISC INJURY | 1 0.01 43.23 INTERVERTEBRAL DISC PROTRUSION | 11 0.11 43.34 INTRAOCULAR PRESSURE TEST ABNORMAL | 1 0.01 43.35 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 43.36 IRON DEFICIENCY | 3 0.03 43.39 IRON DEFICIENCY ANAEMIA | 3 0.03 43.42 IRON METABOLISM DISORDER | 1 0.01 43.43 IRON OVERLOAD | 16 0.16 43.59 IRRITABLE BOWEL SYNDROME | 5 0.05 43.64 ISCHAEMIC CARDIOMYOPATHY | 8 0.08 43.72 JOINT ARTHROPLASTY | 1 0.01 43.73 JOINT INJURY | 2 0.02 43.75 JUVENILE ARTHRITIS | 4 0.04 43.79 KAPOSI'S SARCOMA | 1 0.01 43.80 KIDNEY INFECTION | 2 0.02 43.82 KIDNEY TRANSPLANT REJECTION | 5 0.05 43.87 KNEE ARTHROPLASTY | 2 0.02 43.89 KNEE OPERATION | 1 0.01 43.90 LABYRINTHITIS | 2 0.02 43.92 LACRIMATION INCREASED | 1 0.01 43.93 LACUNAR INFARCTION | 1 0.01 43.94 LARYNGITIS | 1 0.01 43.95 LARYNGOSPASM | 1 0.01 43.96 LEUKAEMIA | 2 0.02 43.98 LEUKAEMIA PLASMACYTIC | 1 0.01 43.99 LEUKOCYTOSIS | 2 0.02 44.01 LIP DRY | 1 0.01 44.02 LIPODYSTROPHY ACQUIRED | 1 0.01 44.03 LIVER ABSCESS | 1 0.01 44.04 LIVER FUNCTION TEST ABNORMAL | 1 0.01 44.05 LIVER TRANSPLANT | 9 0.09 44.14 LIVER TRANSPLANT REJECTION | 1 0.01 44.15 LOCALISED INFECTION | 2 0.02 44.17 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 44.18 LUMBAR SPINAL STENOSIS | 1 0.01 44.19 LUNG ADENOCARCINOMA | 4 0.04 44.23 LUNG ADENOCARCINOMA STAGE IV | 3 0.03 44.26 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 11 0.11 44.37 LUNG DISORDER | 6 0.06 44.43 LUNG INFECTION | 3 0.03 44.46 LUNG NEOPLASM | 1 0.01 44.47 LUNG NEOPLASM MALIGNANT | 10 0.10 44.57 LUNG TRANSPLANT | 1 0.01 44.58 LUPUS NEPHRITIS | 1 0.01 44.59 LYMPHADENOPATHY | 1 0.01 44.60 LYMPHOMA | 1 0.01 44.61 LYMPHOPROLIFERATIVE DISORDER | 3 0.03 44.64 MACULAR DEGENERATION | 2 0.02 44.66 MAINTENANCE OF ANAESTHESIA | 5 0.05 44.71 MAJOR DEPRESSION | 14 0.14 44.85 MALAISE | 3 0.03 44.88 MALARIA | 1 0.01 44.89 MALARIA PROPHYLAXIS | 1 0.01 44.90 MALIGNANT MELANOMA | 21 0.21 45.11 MALIGNANT MELANOMA STAGE III | 12 0.12 45.23 MALIGNANT NEOPLASM OF AMPULLA OF VATER | 1 0.01 45.24 MALIGNANT NEOPLASM OF ISLETS OF LANGE.. | 1 0.01 45.25 MALIGNANT SOFT TISSUE NEOPLASM | 2 0.02 45.27 MALIGNANT URINARY TRACT NEOPLASM | 1 0.01 45.28 MALNUTRITION | 3 0.03 45.31 MANIA | 3 0.03 45.34 MASTOIDITIS | 1 0.01 45.35 MATERNAL EXPOSURE DURING PREGNANCY | 13 0.13 45.48 MEDICAL DIET | 10 0.10 45.58 MELAS SYNDROME | 1 0.01 45.59 MEMORY IMPAIRMENT | 4 0.04 45.63 MENOPAUSAL SYMPTOMS | 3 0.03 45.66 MENOPAUSE | 1 0.01 45.67 MENORRHAGIA | 13 0.13 45.80 MENSTRUAL CYCLE MANAGEMENT | 7 0.07 45.87 MENSTRUAL DISORDER | 1 0.01 45.88 MENSTRUATION IRREGULAR | 7 0.07 45.95 MENTAL DISORDER | 2 0.02 45.97 MESOTHELIOMA MALIGNANT | 2 0.02 45.99 METASTASES TO BONE | 24 0.24 46.23 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 46.24 METASTASES TO LIVER | 2 0.02 46.26 METASTASES TO LYMPH NODES | 2 0.02 46.28 METASTASIS | 1 0.01 46.29 METASTATIC GASTRIC CANCER | 3 0.03 46.32 METASTATIC MALIGNANT MELANOMA | 2 0.02 46.34 METASTATIC NEOPLASM | 3 0.03 46.37 METASTATIC PAIN | 2 0.02 46.39 METASTATIC RENAL CELL CARCINOMA | 8 0.08 46.47 MICTURITION URGENCY | 3 0.03 46.50 MIGRAINE | 38 0.38 46.88 MIGRAINE PROPHYLAXIS | 1 0.01 46.89 MIGRAINE WITHOUT AURA | 1 0.01 46.90 MINERAL SUPPLEMENTATION | 6 0.06 46.96 MITRAL VALVE DISEASE | 1 0.01 46.97 MITRAL VALVE PROLAPSE | 2 0.02 46.99 MITRAL VALVE REPAIR | 1 0.01 47.00 MOBILITY DECREASED | 1 0.01 47.01 MOOD ALTERED | 2 0.02 47.03 MOOD SWINGS | 1 0.01 47.04 MOUTH ULCERATION | 1 0.01 47.05 MUCOPOLYSACCHARIDOSIS II | 4 0.04 47.09 MULTIFOCAL MOTOR NEUROPATHY | 1 0.01 47.10 MULTIPLE ALLERGIES | 10 0.10 47.20 MULTIPLE MYELOMA | 88 0.88 48.08 MULTIPLE SCLEROSIS | 852 8.52 56.60 MULTIPLE SCLEROSIS RELAPSE | 5 0.05 56.65 MUSCLE RELAXANT THERAPY | 5 0.05 56.70 MUSCLE RIGIDITY | 1 0.01 56.71 MUSCLE SPASMS | 15 0.15 56.86 MUSCLE SPASTICITY | 7 0.07 56.93 MUSCULAR WEAKNESS | 2 0.02 56.95 MUSCULOSKELETAL CHEST PAIN | 2 0.02 56.97 MUSCULOSKELETAL DISCOMFORT | 1 0.01 56.98 MUSCULOSKELETAL PAIN | 9 0.09 57.07 MYALGIA | 2 0.02 57.09 MYASTHENIC SYNDROME | 1 0.01 57.10 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 6 0.06 57.16 MYELITIS TRANSVERSE | 1 0.01 57.17 MYELODYSPLASTIC SYNDROME | 17 0.17 57.34 MYELOID LEUKAEMIA | 1 0.01 57.35 MYOCARDIAL INFARCTION | 9 0.09 57.44 MYOCARDIAL ISCHAEMIA | 2 0.02 57.46 NASAL CONGESTION | 3 0.03 57.49 NASAL DISCOMFORT | 3 0.03 57.52 NASAL DRYNESS | 1 0.01 57.53 NASAL ULCER | 2 0.02 57.55 NASOPHARYNGEAL CANCER | 2 0.02 57.57 NASOPHARYNGITIS | 3 0.03 57.60 NAUSEA | 19 0.19 57.79 NECK INJURY | 2 0.02 57.81 NECK PAIN | 6 0.06 57.87 NEOPLASM | 6 0.06 57.93 NEOPLASM MALIGNANT | 3 0.03 57.96 NEPHRITIS | 1 0.01 57.97 NEPHROGENIC ANAEMIA | 6 0.06 58.03 NEPHROTIC SYNDROME | 1 0.01 58.04 NERVE INJURY | 2 0.02 58.06 NERVOUS SYSTEM DISORDER | 3 0.03 58.09 NERVOUSNESS | 2 0.02 58.11 NEURALGIA | 18 0.18 58.29 NEUROENDOCRINE CARCINOMA | 2 0.02 58.31 NEUROENDOCRINE TUMOUR | 3 0.03 58.34 NEUROMUSCULAR BLOCKADE | 1 0.01 58.35 NEUROMYOPATHY | 1 0.01 58.36 NEUROPATHY PERIPHERAL | 11 0.11 58.47 NEUTROPENIA | 5 0.05 58.52 NICOTINE DEPENDENCE | 3 0.03 58.55 NIGHT SWEATS | 1 0.01 58.56 NIGHTMARE | 1 0.01 58.57 NOCTURIA | 1 0.01 58.58 NON-HODGKIN'S LYMPHOMA | 21 0.21 58.79 NON-SMALL CELL LUNG CANCER | 57 0.57 59.36 NON-SMALL CELL LUNG CANCER STAGE III | 3 0.03 59.39 NUCLEAR MAGNETIC RESONANCE IMAGING | 6 0.06 59.45 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 59.46 NUTRITIONAL SUPPORT | 7 0.07 59.53 OBESITY | 7 0.07 59.60 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 59.62 OBSESSIVE-COMPULSIVE PERSONALITY DISO.. | 1 0.01 59.63 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 59.64 OCULAR HYPERAEMIA | 1 0.01 59.65 OCULAR HYPERTENSION | 1 0.01 59.66 OCULAR PEMPHIGOID | 2 0.02 59.68 OEDEMA | 12 0.12 59.80 OEDEMA DUE TO RENAL DISEASE | 1 0.01 59.81 OEDEMA PERIPHERAL | 6 0.06 59.87 OESOPHAGEAL ADENOCARCINOMA | 7 0.07 59.94 OESOPHAGEAL CARCINOMA | 3 0.03 59.97 OESOPHAGEAL SPASM | 3 0.03 60.00 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 60.01 OESOPHAGEAL ULCER | 1 0.01 60.02 OESOPHAGITIS | 2 0.02 60.04 OFF LABEL USE | 2 0.02 60.06 ONCHOCERCIASIS | 1 0.01 60.07 OPEN ANGLE GLAUCOMA | 1 0.01 60.08 OPEN WOUND | 2 0.02 60.10 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 60.11 ORAL CANDIDIASIS | 1 0.01 60.12 ORAL CONTRACEPTION | 16 0.16 60.28 ORAL HERPES | 2 0.02 60.30 OROPHARYNGEAL PAIN | 2 0.02 60.32 ORTHOSTATIC HYPOTENSION | 1 0.01 60.33 OSTEOARTHRITIS | 15 0.15 60.48 OSTEOMYELITIS | 8 0.08 60.56 OSTEOPENIA | 35 0.35 60.91 OSTEOPETROSIS | 1 0.01 60.92 OSTEOPOROSIS | 224 2.24 63.16 OSTEOPOROSIS POSTMENOPAUSAL | 10 0.10 63.26 OSTEOPOROSIS PROPHYLAXIS | 14 0.14 63.40 OSTEOPOROTIC FRACTURE | 1 0.01 63.41 OVARIAN CANCER | 5 0.05 63.46 OVARIAN CANCER METASTATIC | 1 0.01 63.47 OVARIAN CANCER RECURRENT | 6 0.06 63.53 OVARIAN CYST | 10 0.10 63.63 PAIN | 199 1.99 65.62 PAIN IN EXTREMITY | 11 0.11 65.73 PAIN MANAGEMENT | 2 0.02 65.75 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 5 0.05 65.80 PALPITATIONS | 3 0.03 65.83 PANCREAS TRANSPLANT | 1 0.01 65.84 PANCREATIC CARCINOMA | 4 0.04 65.88 PANCREATIC CARCINOMA METASTATIC | 1 0.01 65.89 PANCREATIC CARCINOMA RECURRENT | 1 0.01 65.90 PANCREATIC CARCINOMA STAGE IV | 1 0.01 65.91 PANCREATIC NEUROENDOCRINE TUMOUR | 1 0.01 65.92 PANCREATIC NEUROENDOCRINE TUMOUR META.. | 1 0.01 65.93 PANCREATITIS CHRONIC | 1 0.01 65.94 PANIC ATTACK | 7 0.07 66.01 PANIC DISORDER | 9 0.09 66.10 PARAESTHESIA | 1 0.01 66.11 PARANOIA | 1 0.01 66.12 PARAPLEGIA | 1 0.01 66.13 PARATHYROID DISORDER | 1 0.01 66.14 PARKINSON'S DISEASE | 21 0.21 66.35 PARKINSONISM | 5 0.05 66.40 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 8 0.08 66.48 PARTIAL SEIZURES | 4 0.04 66.52 PEMPHIGOID | 4 0.04 66.56 PERIARTHRITIS | 1 0.01 66.57 PERIODIC LIMB MOVEMENT DISORDER | 1 0.01 66.58 PERIOPERATIVE ANALGESIA | 2 0.02 66.60 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 3 0.03 66.63 PERIPHERAL EMBOLISM | 1 0.01 66.64 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 1 0.01 66.65 PERIPHERAL VASCULAR DISORDER | 1 0.01 66.66 PERIPROCTITIS | 2 0.02 66.68 PERITONEAL DIALYSIS | 149 1.49 68.17 PHYTOTHERAPY | 1 0.01 68.18 PITUITARY TUMOUR | 1 0.01 68.19 PLATELET AGGREGATION ABNORMAL | 1 0.01 68.20 PLATELET COUNT DECREASED | 2 0.02 68.22 PNEUMONIA | 16 0.16 68.38 PNEUMONIA NECROTISING | 2 0.02 68.40 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 68.41 PNEUMONITIS | 1 0.01 68.42 POLLAKIURIA | 4 0.04 68.46 POLYCYTHAEMIA | 1 0.01 68.47 POLYCYTHAEMIA VERA | 1 0.01 68.48 POLYMYALGIA RHEUMATICA | 2 0.02 68.50 POLYMYOSITIS | 7 0.07 68.57 POLYNEUROPATHY | 1 0.01 68.58 POLYURIA | 1 0.01 68.59 POOR PERIPHERAL CIRCULATION | 1 0.01 68.60 POST COITAL CONTRACEPTION | 54 0.54 69.14 POST GASTRIC SURGERY SYNDROME | 1 0.01 69.15 POST HERPETIC NEURALGIA | 3 0.03 69.18 POST PROCEDURAL COMPLICATION | 1 0.01 69.19 POST-TRAUMATIC STRESS DISORDER | 4 0.04 69.23 POSTMENOPAUSE | 1 0.01 69.24 POSTOPERATIVE CARE | 2 0.02 69.26 POSTPARTUM DEPRESSION | 1 0.01 69.27 PRECOCIOUS PUBERTY | 1 0.01 69.28 PREGNANCY | 6 0.06 69.34 PREMATURE EJACULATION | 1 0.01 69.35 PREMEDICATION | 55 0.55 69.90 PREMENSTRUAL SYNDROME | 47 0.47 70.37 PRENATAL CARE | 1 0.01 70.38 PROCEDURAL PAIN | 3 0.03 70.41 PRODUCT USED FOR UNKNOWN INDICATION | 1,211 12.11 82.52 PRODUCTIVE COUGH | 4 0.04 82.56 PROLACTINOMA | 1 0.01 82.57 PROPHYLACTIC CHEMOTHERAPY | 1 0.01 82.58 PROPHYLAXIS | 176 1.76 84.34 PROPHYLAXIS AGAINST ALCOHOLIC WITHDRA.. | 2 0.02 84.36 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 9 0.09 84.45 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 12 0.12 84.57 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 1 0.01 84.58 PROPHYLAXIS OF NAUSEA AND VOMITING | 8 0.08 84.66 PROPHYLAXIS OF NEURAL TUBE DEFECT | 2 0.02 84.68 PROPHYLAXIS URINARY TRACT INFECTION | 2 0.02 84.70 PROSTATE CANCER | 29 0.29 84.99 PROSTATE CANCER METASTATIC | 14 0.14 85.13 PROSTATE INFECTION | 1 0.01 85.14 PROSTATIC DISORDER | 1 0.01 85.15 PROSTATITIS | 4 0.04 85.19 PROSTATOMEGALY | 2 0.02 85.21 PROTEIN URINE | 1 0.01 85.22 PROTEINURIA | 1 0.01 85.23 PRURITUS | 12 0.12 85.35 PSEUDOMONAS INFECTION | 3 0.03 85.38 PSORIASIS | 45 0.45 85.83 PSORIATIC ARTHROPATHY | 36 0.36 86.19 PSYCHOSOMATIC DISEASE | 1 0.01 86.20 PSYCHOTIC BEHAVIOUR | 1 0.01 86.21 PSYCHOTIC DISORDER | 18 0.18 86.39 PULMONARY ARTERIAL HYPERTENSION | 62 0.62 87.01 PULMONARY EMBOLISM | 3 0.03 87.04 PULMONARY HYPERTENSION | 10 0.10 87.14 PULMONARY TUBERCULOSIS | 5 0.05 87.19 PULSE ABNORMAL | 1 0.01 87.20 PUSTULAR PSORIASIS | 2 0.02 87.22 PYELONEPHRITIS | 1 0.01 87.23 PYREXIA | 17 0.17 87.40 RADIAL NERVE PALSY | 1 0.01 87.41 RASH | 21 0.21 87.62 RAYNAUD'S PHENOMENON | 1 0.01 87.63 RECTAL CANCER | 11 0.11 87.74 RECTAL CANCER STAGE IV | 3 0.03 87.77 REFRACTORY ANAEMIA | 1 0.01 87.78 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 18 0.18 87.96 RENAL CANCER | 4 0.04 88.00 RENAL CANCER METASTATIC | 8 0.08 88.08 RENAL CELL CARCINOMA | 37 0.37 88.45 RENAL COLIC | 1 0.01 88.46 RENAL DISORDER | 4 0.04 88.50 RENAL FAILURE | 6 0.06 88.56 RENAL FAILURE CHRONIC | 17 0.17 88.73 RENAL IMPAIRMENT | 1 0.01 88.74 RENAL TRANSPLANT | 33 0.33 89.07 RESPIRATORY DISORDER | 1 0.01 89.08 RESPIRATORY TRACT CONGESTION | 1 0.01 89.09 RESPIRATORY TRACT INFECTION | 4 0.04 89.13 RESTLESS LEGS SYNDROME | 14 0.14 89.27 RESTLESSNESS | 1 0.01 89.28 RHEUMATOID ARTHRITIS | 227 2.27 91.55 RHINITIS | 2 0.02 91.57 RHINITIS ALLERGIC | 1 0.01 91.58 RHINORRHOEA | 1 0.01 91.59 ROUTINE HEALTH MAINTENANCE | 8 0.08 91.67 SALIVARY HYPERSECRETION | 2 0.02 91.69 SARCOIDOSIS | 1 0.01 91.70 SARCOMA | 7 0.07 91.77 SARCOMA METASTATIC | 5 0.05 91.82 SCAB | 1 0.01 91.83 SCAN WITH CONTRAST | 1 0.01 91.84 SCHIZOAFFECTIVE DISORDER | 12 0.12 91.96 SCHIZOPHRENIA | 79 0.79 92.75 SCHIZOPHRENIA, PARANOID TYPE | 5 0.05 92.80 SCHIZOTYPAL PERSONALITY DISORDER | 1 0.01 92.81 SCIATICA | 4 0.04 92.85 SCLERODERMA | 4 0.04 92.89 SEASONAL ALLERGY | 3 0.03 92.92 SECRETORY ADENOMA OF PITUITARY | 2 0.02 92.94 SEDATION | 4 0.04 92.98 SEDATIVE THERAPY | 2 0.02 93.00 SELF INJURIOUS BEHAVIOUR | 1 0.01 93.01 SENILE OSTEOPOROSIS | 2 0.02 93.03 SEPSIS | 5 0.05 93.08 SEPTIC SHOCK | 2 0.02 93.10 SERONEGATIVE ARTHRITIS | 2 0.02 93.12 SERUM FERRITIN INCREASED | 1 0.01 93.13 SEXUAL DYSFUNCTION | 1 0.01 93.14 SHOCK | 2 0.02 93.16 SICKLE CELL ANAEMIA | 7 0.07 93.23 SINUS CONGESTION | 2 0.02 93.25 SINUS DISORDER | 2 0.02 93.27 SINUS HEADACHE | 1 0.01 93.28 SINUSITIS | 19 0.19 93.47 SINUSITIS BACTERIAL | 1 0.01 93.48 SKIN COSMETIC PROCEDURE | 1 0.01 93.49 SKIN DISORDER | 7 0.07 93.56 SKIN INFECTION | 1 0.01 93.57 SKIN IRRITATION | 1 0.01 93.58 SKIN WRINKLING | 2 0.02 93.60 SLEEP APNOEA SYNDROME | 2 0.02 93.62 SLEEP DISORDER | 30 0.30 93.92 SLEEP DISORDER THERAPY | 1 0.01 93.93 SLEEP TERROR | 1 0.01 93.94 SMALL INTESTINAL OBSTRUCTION | 1 0.01 93.95 SMOKING CESSATION THERAPY | 76 0.76 94.71 SNEEZING | 1 0.01 94.72 SOFT TISSUE DISORDER | 4 0.04 94.76 SOMATOFORM DISORDER | 1 0.01 94.77 SPINAL COLUMN STENOSIS | 4 0.04 94.81 SPINAL CORD COMPRESSION | 1 0.01 94.82 SPONDYLOARTHROPATHY | 3 0.03 94.85 SQUAMOUS CELL CARCINOMA | 4 0.04 94.89 STAPHYLOCOCCAL INFECTION | 6 0.06 94.95 STAPHYLOCOCCAL OSTEOMYELITIS | 1 0.01 94.96 STATUS ASTHMATICUS | 1 0.01 94.97 STEM CELL TRANSPLANT | 2 0.02 94.99 STENT PLACEMENT | 4 0.04 95.03 STEROID THERAPY | 1 0.01 95.04 STOMATITIS | 3 0.03 95.07 STRESS | 2 0.02 95.09 STRESS FRACTURE | 1 0.01 95.10 SUBSTANCE USE | 1 0.01 95.11 SUICIDE ATTEMPT | 11 0.11 95.22 SUPPLEMENTATION THERAPY | 38 0.38 95.60 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 95.61 SWELLING | 3 0.03 95.64 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 95.70 T-CELL LYMPHOMA | 2 0.02 95.72 T-CELL TYPE ACUTE LEUKAEMIA | 1 0.01 95.73 TACHYCARDIA | 3 0.03 95.76 TEETHING | 3 0.03 95.79 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 95.80 TENSION | 1 0.01 95.81 TESTICULAR MALIGNANT TERATOMA STAGE II | 2 0.02 95.83 THALASSAEMIA | 1 0.01 95.84 THALASSAEMIA BETA | 3 0.03 95.87 THERAPEUTIC EMBOLISATION | 1 0.01 95.88 THERAPEUTIC PROCEDURE | 3 0.03 95.91 THROMBOCYTOPENIA | 12 0.12 96.03 THROMBOCYTOPENIA NEONATAL | 2 0.02 96.05 THROMBOCYTOPENIC PURPURA | 1 0.01 96.06 THROMBOSIS | 7 0.07 96.13 THROMBOSIS PROPHYLAXIS | 15 0.15 96.28 THYROID CANCER | 7 0.07 96.35 THYROID DISORDER | 16 0.16 96.51 THYROID THERAPY | 1 0.01 96.52 THYROIDECTOMY | 4 0.04 96.56 TIC | 1 0.01 96.57 TISSUE SEALING | 1 0.01 96.58 TOBACCO USER | 4 0.04 96.62 TONGUE DISCOLOURATION | 2 0.02 96.64 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 96.65 TONSIL CANCER | 3 0.03 96.68 TONSILLITIS | 2 0.02 96.70 TOOTH ABSCESS | 1 0.01 96.71 TOOTH INFECTION | 2 0.02 96.73 TOOTHACHE | 2 0.02 96.75 TOXOPLASMOSIS | 1 0.01 96.76 TRANSIENT ISCHAEMIC ATTACK | 5 0.05 96.81 TRANSPLANT REJECTION | 3 0.03 96.84 TREMOR | 1 0.01 96.85 TRIGEMINAL NEURALGIA | 9 0.09 96.94 TUBERCULOSIS | 2 0.02 96.96 TURNER'S SYNDROME | 1 0.01 96.97 TYPE 1 DIABETES MELLITUS | 16 0.16 97.13 TYPE 2 DIABETES MELLITUS | 152 1.52 98.65 ULCER | 5 0.05 98.70 UNEVALUABLE EVENT | 1 0.01 98.71 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 98.72 UPPER RESPIRATORY TRACT INFECTION | 11 0.11 98.83 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 98.84 URGE INCONTINENCE | 1 0.01 98.85 URINARY INCONTINENCE | 3 0.03 98.88 URINARY RETENTION | 1 0.01 98.89 URINARY TRACT DISORDER | 1 0.01 98.90 URINARY TRACT INFECTION | 20 0.20 99.10 URTICARIA | 3 0.03 99.13 UTERINE CANCER | 4 0.04 99.17 UVEITIS | 2 0.02 99.19 VARICELLA | 1 0.01 99.20 VARICES OESOPHAGEAL | 1 0.01 99.21 VASOSPASM | 1 0.01 99.22 VENTILATION/PERFUSION SCAN | 1 0.01 99.23 VENTRICULAR TACHYCARDIA | 1 0.01 99.24 VERTIGO | 2 0.02 99.26 VITAMIN B COMPLEX DEFICIENCY | 4 0.04 99.30 VITAMIN B12 DEFICIENCY | 2 0.02 99.32 VITAMIN D DEFICIENCY | 2 0.02 99.34 VITAMIN SUPPLEMENTATION | 34 0.34 99.68 VOCAL CORD PARALYSIS | 1 0.01 99.69 VOGT-KOYANAGI-HARADA SYNDROME | 3 0.03 99.72 VOMITING | 9 0.09 99.81 VULVOVAGINAL BURNING SENSATION | 1 0.01 99.82 VULVOVAGINAL DRYNESS | 1 0.01 99.83 VULVOVAGINAL PRURITUS | 1 0.01 99.84 WEGENER'S GRANULOMATOSIS | 2 0.02 99.86 WEIGHT DECREASED | 4 0.04 99.90 WEIGHT INCREASED | 1 0.01 99.91 WHEEZING | 5 0.05 99.96 WHITE BLOOD CELL COUNT | 1 0.01 99.97 WISDOM TEETH REMOVAL | 2 0.02 99.99 WOUND INFECTION | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015